A Real-life Study to Understand the Use and Effects of Palbociclib in US Patients With Breast Cancer
Clinical trial NCT06495164 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06495164
- Sponsor
- Pfizer
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2024-06-24
- Primary completion
- 2026-12-30
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.